热门资讯> 正文

Edwards Lifesciences任命新首席财务官

2026-05-05 04:53

Edwards Lifesciences (EW) appointed Theodora Mistras as chief financial officer effective end of May 2026.
Mistras joins from Viatris (VTRS), where she served as CFO since 2024.
She succeeds Scott Ullem, who is transitioning after over a decade in the role.
Mistras brings extensive experience in healthcare finance, including roles at Citigroup Global Markets and Goldman Sachs.

More on Edwards Lifesciences

Edwards Lifesciences Corporation (EW) Q1 2026 Earnings Call Transcript
Edwards Lifesciences: More Appeal For The Heart
Edwards Lifesciences Corporation (EW) Presents at Leerink Global Healthcare Conference 2026 Transcript
Edwards forecasts 9%-11% 2026 sales growth and $2.95-$3.05 adjusted EPS as TAVR guide rises to 7%-9%
Edwards Lifesciences raises 2026 revenue guidance on bullish Q1 results

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。